Table 2.
Distribution of patients according to underlying liver disease
| Etiology | Surviving (n = 28) | Dead (n = 59) | Total (n = 87) |
| ALD | 4 | 7 | 11 |
| ALD + HCC | 1 | 3 | 4 |
| ALD + HCV | 0 | 3 | 3 |
| HBV | 1 | 3 | 4 |
| HBV + HCC | 3 | 6 | 9 |
| HBV + HDV | 1 | 0 | 1 |
| HCV | 0 | 7 | 7 |
| HCV + HCC | 1 | 0 | 1 |
| HCC | 1 | 3 | 4 |
| PBC | 1 | 5 | 6 |
| PSC | 1 | 3 | 4 |
| PSC + HCC | 0 | 2 | 2 |
| Biliary atresia | 4 | 2 | 6 |
| Hemangioma | 0 | 1 | 1 |
| Cryptogenic | 4 | 5 | 9 |
| Acute failure | 3 | 4 | 7 |
| Autoimmune hepatitis | 1 | 1 | 2 |
| HAV | 1 | 0 | 1 |
| Policystic disease | 0 | 1 | 1 |
| Laennec's cirrhosis | 1 | 0 | 1 |
| Wilson disease | 0 | 1 | 1 |
| Langerhans' cell histiocytosis | 0 | 1 | 1 |
| NRH | 0 | 1 | 1 |
ALD: Alcoholic liver disease; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; PBC: Primary biliary chirosis; PSC: Primary sclerosing cholangitis; NRH: Nodular regenerative hyperplasia; HAV: Hepatitis A virus; HBV: Hepatitis B virus.